This disclosure features compounds of Formula I (and their pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes (STING). Said compounds are useful, e.g., for treating a condition, disease or disorder in which increased (e.g., excessive) STING activation (e.g., STING signaling) contributes to the pathology and/or symptoms and/or progression of the condition, disease or disorder (e.g., cancer) in a subject (e.g., a human). This disclosure also features compositions containing the same as well as methods of using and making the same.
本公开涉及式I化合物(以及其药学上可接受的盐、
水合物、共晶体和/或该化合物的药物组合物),其抑制(例如拮抗)干扰素
基因刺激器(STING)。这些化合物是有用的,例如,用于治疗在其中增加(例如过度)STING激活(例如STING信号传导)有助于病理学和/或症状和/或疾病或障碍(例如癌症)在受试者(例如人类)中的进展的情况,疾病或障碍。本公开还涉及含有相同化合物的组合物以及使用和制备相同化合物的方法。